Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today: Donate
Equal access to drugs that treat both a brain tumour and associated conditions, as well as the related financial burden, is an important issue for brain tumour patients and their families across Canada. Where a patient lives should never determine the treatment for a brain tumour.
The diagnosis of a brain tumour can be overwhelming and confusion about access to drugs is an unnecessary burden. Quite simply, it is confusing for patients and families to see provincial health care plans making different decisions based on the same evidence. We adovcate for better access to all brain tumour drugs and increased transparency and collaboration among all stakeholders with the aim to help every Canadian affected by a brain tumour.
And so, any time there is an opportunity for patients to have their voices heard about access to medication is important and Brain Tumour Foundation of Canada supports patient advocacy on this issue.
The treatment of a brain tumour can vary widely depending on its type and location, the age of a patient and many other individual elements. But treatment should be defined by an individual's medical needs and should never be determined by cost or where a patient lives. Find out more about this issue at CanCertainty.ca and lend your voice to the call for fairness.
Equal access to treatments and drugs and the associated financial burden is an important issue for brain tumour patients and their families in Canada. Brain Tumour Foundation of Canada is active on this complex issue in the following ways:
Watch this space for future opportunties to lend your voice to this important issue.
We are celebrating bringing hope for 35 years! One of the ways we are marking this important milestone and sharing hope for the future, is with this video, where Steve Northey, one of our Founders, talks about why this organization started and how far we have come!Learn more
The best Christmas gift I could get would be to get this lump of coal out of my head. However, I do have good days. And recently, a lot...Learn more
Stephen was diagnosed with an anaplastic oligodendroglioma (grade III) in November of 2015 at the age of 53 years old, and shares his...Learn more